APVO
Aptevo Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.84
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-61.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | White Marvin L · director, officer: Executive Chair | M-Exempt | 1,666 | $0.00 |
| Aug 10, 2026 | Abdun-Nabi Daniel · director | M-Exempt | 400 | $0.00 |
| Aug 10, 2026 | White Marvin L · director, officer: Executive Chair | F-InKind | 406 | $4.07 |
| Aug 10, 2026 | Kunz Barbara Lopez · director | M-Exempt | 400 | $0.00 |
| Aug 10, 2026 | Niederhuber John · director | M-Exempt | 400 | $0.00 |
| Aug 10, 2026 | Huebner Dirk · officer: SVP, CMO | F-InKind | 156 | $4.07 |
| Aug 10, 2026 | Huebner Dirk · officer: SVP, CMO | M-Exempt | 638 | $0.00 |
| Aug 10, 2026 | Harsanyi Zsolt · director | M-Exempt | 400 | $0.00 |
| Aug 10, 2026 | Lamothe Jeffrey G. · director, officer: President and CEO | M-Exempt | 961 | $0.00 |
| Aug 10, 2026 | Taylor Daphne · officer: SVP, CFO | M-Exempt | 638 | $0.00 |
| Aug 10, 2026 | Kwon SoYoung · officer: SVP, GC, BD & Corp Affairs | M-Exempt | 638 | $0.00 |
| Aug 10, 2026 | Grant Grady III · director | M-Exempt | 400 | $0.00 |
| Aug 10, 2026 | White Marvin L · director, officer: Executive Chair | M-Exempt | 1 | $0.00 |
| Nov 12, 2025 | Grant Grady III · director | Purchase | 13,513 | $1.49 |
| Aug 8, 2025 | Lamothe Jeffrey G. · officer: EVP, COO | A-Award | 17,300 | $0.00 |
| Aug 8, 2025 | Abdun-Nabi Daniel · director | A-Award | 7,200 | $0.00 |
| Aug 8, 2025 | Kunz Barbara Lopez · director | A-Award | 7,200 | $0.00 |
| Aug 8, 2025 | Kwon SoYoung · officer: SVP, GC, BD & Corp Affairs | A-Award | 11,500 | $0.00 |
| Aug 8, 2025 | Harsanyi Zsolt · director | A-Award | 7,200 | $0.00 |
| Aug 8, 2025 | Niederhuber John · director | A-Award | 7,200 | $0.00 |
| Aug 8, 2025 | Huebner Dirk · officer: SVP, CMO | A-Award | 11,500 | $0.00 |
| Aug 8, 2025 | Grant Grady III · director | A-Award | 7,200 | $0.00 |
| Aug 8, 2025 | Taylor Daphne · officer: SVP, CFO | A-Award | 11,500 | $0.00 |
| Aug 8, 2025 | White Marvin L · director, officer: President and CEO | A-Award | 30,000 | $0.00 |
| Jul 21, 2025 | Grant Grady III · director | M-Exempt | 1 | $0.00 |
| Jul 21, 2025 | Kwon SoYoung · officer: SVP, GC, BD & Corp Affairs | M-Exempt | 3 | $0.00 |
| Jul 21, 2025 | White Marvin L · director, officer: President and CEO | M-Exempt | 10 | $0.00 |
| Jul 21, 2025 | Lamothe Jeffrey G. · officer: EVP, COO | M-Exempt | 5 | $0.00 |
| Jul 21, 2025 | Niederhuber John · director | M-Exempt | 1 | $0.00 |
| Jul 21, 2025 | Harsanyi Zsolt · director | M-Exempt | 1 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 3Reduced 3Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | Increased | 21,539 | Aug 6, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 19,638 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 13,337 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 12,713 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 12,713 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 10,821 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 4,142 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 4,142 | Aug 13, 2026 |
| UBS GROUP AG | Increased | 3,445 | May 5, 2026 |
| UBS Group AG | Reduced | 730 | Aug 13, 2026 |
| OSAIC HOLDINGS, INC. | Unchanged | 360 | Aug 14, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Unchanged | 360 | May 15, 2026 |
| SBI Securities Co., Ltd. | Unchanged | 109 | Jul 23, 2026 |
| SBI SECURITIES CO., LTD. | Increased | 109 | Apr 28, 2026 |
| BARCLAYS PLC | New Position | 31 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026